BNTC today
$9.10-$0.37 (-3.91%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $9.29
Key levels
Resistance$10.23
Resistance$9.29
Support$7.88
Support$7.05
Latest news & SEC filings
ProductBenitec Biopharma reports encouraging early data for BB-301 in OPMD
ProductBenitec Biopharma reports interim BB-301 Phase 1b/2a data showing durable improvements
All BNTC news →About Benitec Biopharma
Benitec Biopharma develops gene-based treatments for genetic disorders. Its main candidate, BB-301, targets oculopharyngeal muscular dystrophy using a technique that silences faulty genes and supplies working copies. The company is headquartered in California and has operations in Australia.
Based on the company's 10-K filed Sep 14, 2026.
Nasdaq · Healthcare
Benitec Biopharma Inc. (BNTC)
What Is the Price Target for BNTC?
SEPT Low Target
$14.00
SEPT Mid Target
$17.00
SEPT High Target
$25.00
Analyst Consensus
$17.00
Is BNTC a Buy or Sell Right Now?
Thesis
- •Revenue growing 2.7% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BNTC.
Start Free Trial →Is BNTC Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$15.19
12
Moat Score
NONE
2/9
Piotroski Score
40.4
Altman Z-Score
What Is Smart Money Doing with BNTC?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BNTC Growth Story
Revenue YoY
2.7%
3yr Revenue CAGR
N/A%
EPS Growth YoY
6.67%
FCF Growth YoY
15.1%
Revenue Trend
UNKNOWN
Dark Pool Trades for BNTC
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BNTC, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:51:16 | $9.15 | 6,000 | $$55K | BUY |
| 16:50:59 | $9.00 | 6,000 | $$54K | SELL |
| 21:00:31 | $9.47 | 1,200 | $$11K | MIDPOINT |
| 19:01:45 | $9.37 | 1,720 | $$16K | SELL |
| 18:37:35 | $9.25 | 2,294 | $$21K | BUY |
5 dark pool trades shown · $$158K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Benitec Biopharma Inc. (BNTC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BNTC — frequently asked questions
What is BNTC stock price today?
Benitec Biopharma Inc. (BNTC) is at $9.10, down 3.91% (-$0.37) at the Nov 12, 2026 close.
Why is BNTC stock moving today?
Latest BNTC news — Oct 28, 2026: Benitec Biopharma reports encouraging early data for BB-301 in OPMD · Oct 28, 2026: Benitec Biopharma reports interim BB-301 Phase 1b/2a data showing durable improvements
What is the BNTC price target?
The average analyst price target for BNTC is $17.00, ranging from $14 to $25, based on 3 analysts. Latest: Raymond James initiates on Oct 23, 2026.
What do analysts rate BNTC?
Analyst ratings for BNTC: 0 Buy, 5 Hold, 0 Sell — consensus Hold.
Did BNTC beat earnings?
BNTC last reported on Sep 14, 2026: EPS -$0.26 vs -$0.26 expected — a beat of 1.6%.
Does BNTC pay a dividend?
BNTC does not currently pay a dividend.
What are BNTC support and resistance levels?
Support: $7.88, $7.05, $5.74. Resistance: $9.29, $10.23, $10.99.
What are insiders doing with BNTC?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on BNTC?
Oct 28, 2026: Benitec Biopharma reports encouraging early data for BB-301 in OPMD · Oct 28, 2026: Benitec Biopharma reports interim BB-301 Phase 1b/2a data showing durable improvements